Want to see APRE full AI Analyst Report?
Aprea Therapeutics (APRE) Ownership - Who Owns Aprea Therapeutics?
Aprea Therapeutics (APRE) Ownership Overview
- 6.39% Insiders
- 0.73% Mutual Funds
- 16.16% Other Institutional Investors
- 0.39% ETFs
- 76.32% Public Companies and Individual Investors
The ownership structure of Aprea Therapeutics (APRE) stock is a mix of institutional, retail, and individual investors. Approximately 17.29% of the company’s stock is owned by Institutional Investors, 6.39% is owned by Insiders, and 76.32% is owned by Public Companies and Individual Investors.
The ownership structure of Aprea Therapeutics (APRE) stock is a mix of institutional, retail, and individual investors. Approximately 16.90% of the company’s stock is owned by Institutional Investors, 6.39% is owned by Insiders, and 0.39% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Feb 01, 2026 | Oren Gilad | $25,009 | |
| Feb 01, 2026 | John P. Hamill | $5,073 | |
| Dec 10, 2025 | Marc Duey | $24,892 | |
| Dec 10, 2025 | John P. Hamill | $5,800 |
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Oren Gilad | 395,695 | Insider | 3.14% | 191,516 |
| Marc Duey | 259,892 | Insider | 2.06% | 125,788 |
| Fidelity Concord Street Trust | 72,669 | Institution | 0.58% | 35,172 |
| Vanguard | 49,212 | Institution | 0.39% | 23,819 |
| Bernd R. Seizinger | 48,910 | Insider | 0.39% | 23,672 |
| John P. Hamill | 43,528 | Insider | 0.35% | 21,068 |
| Rifat Pamukcu | 22,689 | Insider | 0.18% | 10,981 |
| Vanguard Index Funds | 19,622 | Institution | 0.16% | 9,497 |
| John Henneman | 13,364 | Insider | 0.11% | 6,468 |
| Richard Peters | 6,254 | Insider | 0.05% | 3,027 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 72,669 | Institution | 0.58% | 35,172 |
| Vanguard Index Funds | 19,622 | Institution | 0.16% | 9,497 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 49,212 | Institution | 0.39% | 36,909 |
FAQ
Who Owns Aprea Therapeutics (APRE)?
According to the latest TipRanks data, approximately 16.16% of the company's stock is held by institutional investors, 6.39% is held by insiders, and 76.32% is held by retail investors.
What percentage of Aprea Therapeutics (APRE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.16% of Aprea Therapeutics (APRE) stock is held by institutional investors.
What percentage of Aprea Therapeutics (APRE) stock is held by retail investors?
According to the latest TipRanks data, approximately 76.32% of Aprea Therapeutics (APRE) stock is held by retail investors.
Who owns the most shares of Aprea Therapeutics (APRE)?
Oren Gilad owns the most shares of Aprea Therapeutics (APRE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.